Reports for Drugs for Neglected Diseases initiative (DNDi)
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Drugs for Neglected Diseases initiative (DNDi)
- Drugs for Neglected Diseases initiative (DNDi) has its legal headquarters in Genève and is active. It is a Foundation and active in the industry «Religious, political or secular associations».
- Drugs for Neglected Diseases initiative (DNDi) has 33 persons entered in its management.
- The organization has last changed their commercial register entry on 05.08.2025, under «Notifications» you will find all changes.
- The organization Drugs for Neglected Diseases initiative (DNDi) is registered under the UID CHE-110.141.200.
- There are currently 2 trademarks or applications for the organization Drugs for Neglected Diseases initiative (DNDi) in the IPI database.
- Companies with an identical address: GARDP Foundation, Phoenix Resource Association.
Management (33)
newest members of the Foundation Board
Yasmine Belkaid,
Mariciana Onono,
Rajiv Bahl,
Silvia Gold Turjanski,
Kristine Husoey Onarheim
newest authorized signatories
Fabienne Benoist,
Frédéric Monnot,
Anderson Augusto Teixeira Leal,
Pascal Dominique Carpentier,
Stéphane Hugonnet
Commercial register information
Entry in the commercial register
11.07.2003
Legal form
Foundation
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-660.1.390.003-7
UID/VAT
CHE-110.141.200
Sector
Religious, political or secular associations
Purpose (Original language)
Encourager et soutenir la recherche et le développement principalement de médicaments, ainsi que de vaccins et de diagnostics contre les maladies négligées; favoriser l'accès et le développement équitables de nouveaux médicaments, promouvoir de nouvelles formules des médicaments existants, encourager la production de médicaments efficaces connus, la recherche de méthodes de diagnostic et/ou de vaccins contre les maladies négligées; adapter de nouveaux traitements contre les maladies négligées, de manière à satisfaire les besoins des patients, et répondre aux exigences liées aux capacités de production de médicaments et à leurs conditions d'administration dans les pays en voie de développement; susciter une prise de conscience du besoin de recherche et de développement de médicaments contre les maladies négligées.
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Deloitte SA | Genève | 20.04.2007 | ||
Former auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Ernst & Young SA | Lancy | <2004 | 24.05.2007 | |
Other company names
Past and translated company names
- Drugs for Neglected Diseases initiative DNDi
Branches (0)
Ownership structure
Holdings
Trademarks
| Trademark | Registration date | Status | Number |
|---|---|---|---|
| - | pending application | 11057/2025 | |
| to the trademark | 25.04.2008 | active | 63417/2007 |
Newest SOGC notifications: Drugs for Neglected Diseases initiative (DNDi)
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006401511, Commercial Registry Office Geneva, (660)
Drugs for Neglected Diseases initiative (DNDi), à Genève, CHE-110.141.200, fondation (FOSC du 15.05.2025, p. 0/1006333028). Signature collective à deux, avec le directeur général, Vielfaure Laurence, Fraisse Laurent, Stobbaerts Eric ou Paye Rudi, a été conférée à Benoist Fabienne, de France, à Ferney-Voltaire, FRA, directrice.
Publication number: HR02-1006333028, Commercial Registry Office Geneva, (660)
Drugs for Neglected Diseases initiative (DNDi), à Genève, CHE-110.141.200 (FOSC du 27.12.2024, p. 0/1006217583). Signature collective à deux, avec le directeur général, Fraisse Laurent, Paye Rudi, Vielfaure Laurence ou Stobbaerts Eric a été conférée à Monnot Frédéric, de France, à Excenevex, FRA, directeur.
Publication number: HR02-1006217583, Commercial Registry Office Geneva, (660)
Drugs for Neglected Diseases initiative (DNDi), à Genève, CHE-110.141.200 (FOSC du 18.12.2024, p. 0/1006209337). Mwinga Alwyn Gladwyn n'est plus membre du conseil de fondation.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.